NO980976L - Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflater - Google Patents

Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflater

Info

Publication number
NO980976L
NO980976L NO980976A NO980976A NO980976L NO 980976 L NO980976 L NO 980976L NO 980976 A NO980976 A NO 980976A NO 980976 A NO980976 A NO 980976A NO 980976 L NO980976 L NO 980976L
Authority
NO
Norway
Prior art keywords
methods
attaching
substances
displaying
materials
Prior art date
Application number
NO980976A
Other languages
English (en)
Other versions
NO980976D0 (no
Inventor
Lothar Steidler
Erik Remaut
Jeremy Mark Wells
Original Assignee
Lothar Steidler
Erik Remaut
Jeremy Mark Wells
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lothar Steidler, Erik Remaut, Jeremy Mark Wells filed Critical Lothar Steidler
Publication of NO980976D0 publication Critical patent/NO980976D0/no
Publication of NO980976L publication Critical patent/NO980976L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sheet Holders (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Adhesive Tapes (AREA)

Abstract

Fremgangsmåter for oppnåelse av overflateekspresjon av et ønsket protein eller polypeptid i grampositive vertsorganismer. Vektorer anvendelige ved slike fremgangsmåter, så vel som grampositive vertsorganismer transformert med slike vektorer, er også beskrevet.
NO980976A 1995-09-07 1998-03-06 Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflater NO980976L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518323.2A GB9518323D0 (en) 1995-09-07 1995-09-07 Materials and methods relating to the attachment and display of substances on cell surfaces
PCT/GB1996/002195 WO1997009437A1 (en) 1995-09-07 1996-09-06 Materials and methods relating to the attachment and display of substances on cell surfaces

Publications (2)

Publication Number Publication Date
NO980976D0 NO980976D0 (no) 1998-03-06
NO980976L true NO980976L (no) 1998-05-06

Family

ID=10780370

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980976A NO980976L (no) 1995-09-07 1998-03-06 Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflater

Country Status (16)

Country Link
US (1) US6190662B1 (no)
EP (1) EP0848756B1 (no)
JP (1) JP4180111B2 (no)
KR (1) KR19990044528A (no)
CN (1) CN1201493A (no)
AT (1) ATE270337T1 (no)
AU (1) AU729449B2 (no)
BR (1) BR9610133A (no)
CA (1) CA2231372A1 (no)
DE (1) DE69632827T2 (no)
GB (1) GB9518323D0 (no)
MX (1) MX9801864A (no)
NO (1) NO980976L (no)
NZ (1) NZ316580A (no)
WO (1) WO1997009437A1 (no)
ZA (1) ZA967562B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821088A (en) * 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
DE19735105A1 (de) * 1997-08-13 1999-03-04 Univ Albert Ludwigs Freiburg Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen
EP0916726A1 (en) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Attaching substances to micro-organisms
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1012245A1 (en) * 1998-06-25 2000-06-28 Korea Green Cross Corporation Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein
KR100313135B1 (ko) 1999-02-22 2001-11-05 윤덕용 세포 표면 발현 모체로서의 대장균 유래 세포외막 단백질 ｃ(ｏ
PT1739178E (pt) 1999-07-05 2010-11-17 Actogenix Nv Libertação de péptidos trifólios
IL154284A0 (en) * 2000-09-25 2003-09-17 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
CN1484700A (zh) * 2000-11-02 2004-03-24 �¼��¹�����ѧ aopB基因,蛋白,同系物,片段和它们的变体,以及它们在细胞表面展示方面的应用
EP1239032A1 (en) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
US7780961B2 (en) * 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
JP2005529622A (ja) * 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
US7527966B2 (en) * 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
WO2004041863A2 (en) 2002-11-08 2004-05-21 Ablynx N.V. Single domain antibodies directed against interferon- gamma and uses therefor
EP1558645B1 (en) 2002-11-08 2011-07-27 Ablynx N.V. Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
EP1900753B1 (en) 2002-11-08 2017-08-09 Ablynx N.V. Method of administering therapeutic polypeptides, and polypeptides therefor
AU2003298291A1 (en) * 2002-11-15 2004-06-15 Universiteit Gent Self-containing lactobacillus strain
EP1590443A4 (en) * 2003-01-29 2009-01-07 Osel Inc SURFACE EXPRESSION OF BIOLOGICALLY ACTIVE PROTEINS IN BACTERIA
CA2539452C (en) * 2003-09-17 2013-10-29 Guava Technologies, Inc. Compositions and methods for analysis of target analytes
WO2006083516A2 (en) * 2005-01-12 2006-08-10 Osel, Inc. Modified cyanovirin-n polypeptide
ES2405552T3 (es) 2005-11-29 2013-05-31 Actogenix N.V. Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
WO2008090223A2 (en) 2007-01-25 2008-07-31 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
EP1972350A1 (en) * 2007-03-20 2008-09-24 Rijksuniversiteit Groningen Dual targeting system
WO2009137763A2 (en) * 2008-05-08 2009-11-12 Emory University Methods and compositions for the display of polypeptides on the pili of gram-positive bacteria
EP3181682B1 (en) * 2008-09-29 2021-04-21 Intrexon Actobiotics NV Reduced colonization of microbes at the mucosa
EP2892554B1 (en) 2012-09-07 2020-08-26 Emory University Hiv immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto
EP2897638A1 (en) 2012-09-24 2015-07-29 Montana State University-Bozeman Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use
WO2018208726A1 (en) 2017-05-08 2018-11-15 Rensselaer Polytechnic Institute Multiplex detection of bacterial pathogens via cell wall binding domain complexes
AR118443A1 (es) * 2019-03-19 2021-10-06 Bayer Cropscience Lp Proteínas de fusión, bacterias recombinantes y fragmentos de exosporas para control de plagas y salud de las plantas
AU2021410776A1 (en) * 2020-12-23 2023-05-04 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616686A (en) 1990-05-11 1997-04-01 The Rockefeller University Polypeptide of a hybrid surface protein by bacteria
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
AU674311B2 (en) * 1992-03-13 1996-12-19 Rockefeller University, The Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria

Also Published As

Publication number Publication date
ATE270337T1 (de) 2004-07-15
KR19990044528A (ko) 1999-06-25
AU729449B2 (en) 2001-02-01
US6190662B1 (en) 2001-02-20
JP4180111B2 (ja) 2008-11-12
BR9610133A (pt) 1999-12-21
NO980976D0 (no) 1998-03-06
DE69632827T2 (de) 2005-07-07
EP0848756A1 (en) 1998-06-24
WO1997009437A1 (en) 1997-03-13
CA2231372A1 (en) 1997-03-13
GB9518323D0 (en) 1995-11-08
MX9801864A (es) 1998-11-29
AU6884496A (en) 1997-03-27
HK1014337A1 (en) 1999-09-24
JPH11511983A (ja) 1999-10-19
NZ316580A (en) 1999-09-29
DE69632827D1 (de) 2004-08-05
ZA967562B (en) 1998-03-06
CN1201493A (zh) 1998-12-09
EP0848756B1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
NO980976L (no) Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflater
NO882946L (no) Konstruksjon av syntetisk dna og anvendelse derav i syntese av store polypeptider.
ATE286907T1 (de) Cytokinin-designiertes lerk-5
EP0871702A4 (en) CYTOKINE DESIGNED BY LERK-7
ATE353906T1 (de) Cd27 ligand
ES2072892T3 (es) Proteina receptora para un factor 2 estimulante de celulas b humanas.
NO970155L (no) Kunstig ekstracellulær biologisk matrise samt fremgangsmåte ved fremstilling derav
BR9508053A (pt) Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heteróloga
DE69912870D1 (de) Kosmetische oder dermatologische Zusammensetzung, enthaltend zumindest ein natürliches oder rekombinantes Seidenprotein von Arachniden oder ein analoges Protein
MX9204517A (es) Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia.
BR9507678A (pt) Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura
IT8819024A0 (it) E suo uso. terreno di coltura esente da siero
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE69737978D1 (de) Als 2f1 bezeichnetes rezeptorprotein
DE69130981D1 (de) Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen
KR920702417A (ko) Tcf-ii의 아미노산 배열을 코드하는 dna를 함유한 플라스미드, 형질전환세포, 및 이것을 사용하여 생리 활성물질을 생산하는 방법
NO952039L (no) Proteiner med glykosyltransferase-aktivitet
WO2000069884A3 (en) Compositions isolated from skin cells and methods for their use
DK115189A (da) Sulfateret k5-antigen og sulfaterede k5-antigenfragmenter og fremgangsmaade til fremstilling deraf samt middel indeholdende det sulfaterede k5-antigen eller fragmenter deraf
NO20000575L (no) Rekombinant ekspresjon av insulin C-peptid
AU7423391A (en) Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals
BR9600270A (pt) Utilização de arginina processos de extração de uma proteína periplásmica de interesse e de cultura de um microorganismo procarioto transformado com a ajuda de um vetor de expressão
BR9908250A (pt) Processo para preprar uma emulsão de óleo em água curável, e, emulsão curável de água em óleo
DK161487D0 (da) Alfa-interferon-analoge og fremgangsmaade til fremstilling deraf samt udtrykkelsesvektorer og vaertsorganismer til anvendelse ved fremgangsmaaden.
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung